Skin manifestations associated with diabetes mellitus
DOI:
https://doi.org/10.47196/diab.v48i1.180Keywords:
diabetes, skin manifestationsAbstract
Long-standing diabetes mellitus (DM) with poor metabolic control can produce permanent and irreversible functional changes and damage to organs and tissues, thus producing complications that mainly result from biochemical, structural and functional abnormalities. Poor glycemic control and the development and progression of microvascular complications (retinopathy, nephropathy, and neuropathy) have been causally associated; Due to complications in the microvasculature, any system or organ can be affected and the skin is no exception.
References
Wahiz Z, Kanjee A: Cutaneous manifestations of diabetes mellitus. J Pak Med. Assoc. 1998; 48:304-305.
Mahmood T, Bari A, Agha H: cutaneous manifestations of diabetes mellitus. J Pak. Assoc. Dermatol. 2005; 15:227-232.
Oumeish OY: Skin disorders in patient with diabetes. Clin. Dermatol. 2008; 26:235-242.
Santamaría GV, Barrios E. Manifestaciones cutáneas de la diabetes mellitus. Rev. Cent. Dermatol. Pascua 2001; 10(1)45-56.
Halprin KM, Ohkawara A. Glucose entry into the human epidermis, I: the concentration of glucose in the human epidermis. J Invest. Dermatol. 1967; 49:559-560.
Yosipovitch G, Hodak E, Vardi P, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications in type 2 diabetes. Diabetes Care 1999; 22:1745.
Pérez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am. Acad. Dermatol. 1994; 30:519-531.
Rodríguez E. Manifestaciones cutáneas de la diabetes mellitus. Univ. Med. 2003; 44:179-187.
Romano G, Morreti G, Di Benedetto: Skin lesions in diabetes mellitus: prevalence and clinical correlations. Diabetes Res. Clin. Pract. 1998; 39:101- 06.
Saenz ML. Manifestaciones cutáneas de las enfermedades sistémicas. Rev. Med. Clin. Condes 2011; 22(6)749-756.
Guerra MM, Fernández M, Soler SF, Uribe-Echeverría AI, Rodríguez GA. Estudio de las enfermedades dermatológicas en diabéticos del Centro de Atención al Diabético (CAD) de la provincia de Matanzas, Cub. Año 2003. Rev. Med. Electro. 2008; 30(1).
Kahn CR. Insulin action, diabetogenes and the cause of type II diabetes mellitus. Diabetes 1994; 43:1066-1084.
Cabo H. Manifestaciones cutáneas de la diabetes mellitus. 1º Ed. Héctor A. Macci, Buenos Aires, 1996.
Brownlee M, Vlassara H, Kooney A et al. Aminoguanidine prevent diabetes-induced arterial wall protein crosslinking. Science 1986; 232:1629- 1632.
Delbridge L, Ellis CS, Robertson K et al. Non enzymatic glycosylation of keratin from stratum corneum of the diabetic foot. BR J Dermatol 1985; 112:547-554.
Ngo B, Hayes K, DiMiao D, Srinivasan S, Huerter C, Rendell M. Manifestations of cutaneous diabetic microangiopathy. Am. J Clin. Dermatol. 2005; 6(4):225-237.
Zaballos D, Garrido Calvo A, Cía Blasco P, Esteve Lafuente E, Pinós Laborda P. Manifestaciones cutáneas de la diabetes. Rev Interconsulta, 2001; 15(8):43-50.
Farías M, Kolbach R. Serrano V, Hasson N. Diabetes Mellitus y piel: lesiones cutáneas y su significado clínico. Rev. Chil. Endocrinol. Diabetes 2011; 4(1)26-31.
Páez E. Piel y diabetes mellitus. Dermatol. Venez. 1999; 31(1):40-46.
Ferringer T, Miller O.F. Cutaneous manifestation of diabetes mellitus. Dermatol. Clin. 2002; 20:483-492.
Mark H, Lowitt J y Dover S. Manifestaciones cutáneas de la diabetes mellitus. En Kahn R. y colaboradores. Joslin´s Diabetes Mellitus. 14º Ed. Barcelona, España: Lippincott Williams & Wilkins 2007; 62:1049-1060.
Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus. A longitudinal study in a tertiary care hospital in Gujart. Indian. J Endocr. Metab. 2013; 17(4):659-664.
YosipovitchG, Hodak E, Vardi P, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications in type 2 diabetes. Diabetes Care, 1999; 22:1745.
Freinkel RK. Manifestaciones cutáneas de las enfermedades endocrinas. En Fitzpatrick TB. Dermatología en Medicina General. 5º Ed. Buenos Aires: Médica Panamericana; 2002; 2199-2217.
Sibbald RG, Landolt SJ, Toth D. Skin and diabetes. Endocrinol. Metab. Clin. North Am. 1996; 25(2):463-472.
Morgan A, Schwartz R. Diabetic dermopathy: a subtle sign with grave implications. J Am. Acad. Dermatol. 2008; 58:447-451.
Parra C, Guarda R. La piel en trastornos sistémicos comunes. En: Guarda R. Gubelin W, Ed. Dermatología Esencial. Editorial Mediterráneo 2010; 251-252.
Zaballos D, Garrido Calvo A, Cía Blasco P, Esteve Lafuente E, Pinós Laborda P. Manifestaciones cutáneas de la diabetes. Rev Interconsulta. 2001;15(8):43-50.
Reid S, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: A review of etiology, diagnosis and treatment option. J Am. Acad. Dermatol. 2013;34:5 (abst).
Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 171 cases. Arch. Dermatol. 1966; 93:272- 281.
Paron NG, Lamber PW. Cutaneous manifestations of diabetes mellitus. Prim. Care 2000; 27:371-383.
O´Toole EA, Kennedy U, Nolan JJ, et al. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br. J Dermatol. 1999; 140:283- 286.
Verrotti A. Chiarelli F, Amerio P, et al. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr. Dermat. 1995:12:220-223.
Feel C, Aragües M. Necrobiosis lipoidea. Piel 1999;14: 295-302.
Derrighetti M, Hohl D, Krayenbuhl BH, et al. Bullosus diabeticorum in a newly discovered type 2 diabetes mellitus. Dermatology 2000; 200:366.367.
López S, Becerril F. Manifestaciones cutáneas de la diabetes mellitus, una manera clínica de identificar la enfermedad. Rev. Endocrinol. Nut. 2005; 13(2):75-87.
Jabbour S, et al. Endocrinopathies and the skin. Int. J Dermatol. 2000; 39:88- 99.
Lipsky BA, Baker PD, Ahroni JH. Diabetic bullae: 12 cases of a purportedly rare cutaneous disorder. Int. J Dermatol. 2000; 39:196-200.
Nebesio C, Lewis C, Chuang T. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermato.l 2002; 146:122-124.
Choudry K, Charles-Holmes R. Are patients with localized nodular granuloma annulare more likely to have diabetes mellitus? Clin. Exp. Dermatol. 2000; 25:451-452.
Fleming C, Michelena MA, Garritano MV y col. Haga su diagnóstico. Placas eritematosas en tronco. Granuloma anular generalizado. Arch. Argent. Dermatol. 2011; 61(1):30-33.
Corigliano M, Achembach RE. Granuloma anular: un desafío diagnóstico y terapéutico. Rev. Argent. Dermato. 2012; 93(4).
Fleishmajer R, Faludi G, Krol S. Scleredema and diabetes mellitus. Arch. Dermatol. 1970; 101:21-26.
Cole GW, Headley J, Skowsley R. Scleroderma diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 1983: 6:189-192.
Santamaría G. Manifestaciones cutáneas de la diabetes mellitus. Rev. Fac. Med. UNAM 2003; 46(4):143-147.
Pastor MA, Álvarez P, Mosquera J, Bautista R. Escleredema. Actas Dermofiliofr. 2006; 97(4)287-288.
Ferringer T, Miller O.F. Cutaneous manifestation of diabetes mellitus. Dermatol. Clin. 2002; 20:483-492.
Rosenbloom AL, Silverstein JH, Kubillis PS, et al. Limited joint mobility (LJM) in insulin-dependent diabetes mellitus high risk for microvasculopathy (MVP) Pediatr. Res. 1980;14:580A.
Cabo H, Woscoff A, Casan J. Piel cérea y movilidad articular en pacientes diabéticos. Dermatol. Arg. 1995; 1(2):89-92.
Román J, Pacheco M, Andrade L. La limitación de la movilidad articular en pacientes con diabetes mellitus tipo 2. Rev. Per. Reumatol. 1999; 5(1)21-31.
Dependra KT, Mohan TD, Agrawal A. Estudio clínico de las dermatosis en diabetes mellitus para establecer sus marcadores. Indian J Dermatol. 2012; 57:287-288.
Cabo H, Woscoff A, Casa J. Empedrado digital: marcador temprano de engrosamiento cutáneo en pacientes diabéticos. Arch. Arg. Dermatol. 1993; 43(3):185-192.
Huntley AC. Finger pebbles: a common finding in diabetes mellitus. J Am. Acad. Dermat. 1966; 14:612-617.
Hollister DS, Brodell RT. Finger “pebbles”: a dermatologic sign of diabetes mellitus. Postgrad. Med. 2000; 41:39-41.
Sánchez-Pedreño P. Alteraciones cutáneas en la diabetes mellitus. Actitud diagnóstica y tratamiento. En: Tébar FJ, Escobar F. La diabetes mellitus en la práctica clínica. 1º Ed. Buenos Aires. Médica Panamericana 2009; 43:355- 357.
Requena Caballero L, Martín Moreno L. Manifestaciones cutáneas de la diabetes mellitus. Revisión. Formación Médica Continua 1991; 40(950):77-93.
Hoerer E, Dreyfuss F, Herzerberg M. Carotenemia, skin color and diabetes mellitus. Acta Diabetol Lat 1975;12:202-207.
Orlandi C. Manifestaciones cutáneas de la diabetes mellitus. En: Contreras C, Ed. Diabetes Mellitus. Santiago: Editorial Mediterráneo. 2004;385-392.
Kahn CR, Flier Js, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorder in man. N Engl. J Med.1976; 294:739-745.
Higgins S, Freemark M, Prose n. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol. Online J 2008;14:2.
Dawber RPR, Bleehen SS, Vallance-Owen J. Vitiligo and diabetes mellitus. Br J Dermatol. 1971;84:600.
Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch. Dermatol. 1977; 113:1515-1517.
Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch. Dermatol. 1977;113:1515-1517.
Hann S, Chung H. Historic view of vitiligo in Korea. Int. J Dermatol. 1997; 36:313-315.
Taïeb A, Picardo M, et al. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007;20:27-35.
Ferringer T, Miller O.F. Cutaneous manifestation of diabetes mellitus. Dermatol. Clin. 2002; 20:483-492.
Halevy S, Feurman EJ. Abnormal glucose tolerance associated with lichen planus. Acta Derm. Venereol. 1979; 59:167-170.
Petrou-Amerikanou, Markopolus AK, Belazi M, et al. Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes. Oral Dis. 1998; 4:37-40.
Bagan JV, Donat JS, Penarrocha M, et al. Oral lichen planus and diabetes mellitus: a clinico-pathological study. Bull Group Int. Rech. Sc.i Stomatol. Odontol. 1993; 36:3-6.
Romero MA, Seoane J, Varela P, Diz P, García MJ. Prevalencia de diabetes mellitus en pacientes con liquen plano oral. Características clínicas- patológicas. Med. Oral. 2002; 7:121-129.
Giménez R, Pérez J. Liquen plano y enfermedades asociadas: estudio clínico- epidemiológico. Act. Dermatol. Sifiliog. 2004; 95(3):154-160.
Sánchez L, Cabanillas J, Ponce M, Salluca A. Liquen Plano. Dermatol. Per. 2011;21(1)27-43.
López L, Ramos JA, Petrocelli D, Manríquez A. Xantomas eruptivos como manifestación inicial de diabetes mellitus e hipertrigliceridemia severa. Rev. Cent. Dermatol. Pascua 2010; 19(1):15-18.
Alver R, et al. Xantomas eruptivos como primera manifestación de enfermedad sistémica. Piel, 2009; 19:243-246.
Villalón G, Martín JM, Monteagudo CM, Alonso V, Montesinos E, Jordá E. Xantomas eruptivos en el debut de DM. Actas Dermosifiliogr 2008; 99:426- 427.
Nayak KR, Daly RG. Eruptive xanthomas associated with hipertrigliceridemia and new-onset diabetes mellitus. N Engl. J Med. 2004; 350(12):1235-1236.
Redondo P. Enfermedades autoinmunes de la piel y la diabetes. Av. Diabetol. 2007; 23(3):189-196.
Medani S, Shapiro J. Alopecia areata update. J Am. Acad. Dermatol. 2000; 42:549-566.
De Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M. Alopecia areata in families: association with the HLA Locus. J Invest. Dermatol. Symp. Proc. 1999; 4:220-223.
Wang SJ, Shohat T, Vadheim C, Shellow W, Edwuards J, Rotter JI. Increased risk for type 1 diabetes in elatives of patients with alopecia areata. Am. J Med. Genet. 1994; 51:234-23.
Taniyama M, Kushima K, Ban Y, et al. Simultaneous development of insulin dependent diabetes mellitus and alopecia areata universalis. Am J Med. Sci. 1991;301:269-271.
Kim YJ, Chong BI, Ro BI. Four year alopecia areata study. Rev. Dermatol. Ang University South Korea 2000; 2:18-20.
Jacques L, Darier J. Hidradenomes éruptifs. I. Epithéliomes adenoids des glandes sudoripares ou adenomes sudoripares. Ann Dermatol. Venerol. 1887; 8:317-323.
Haedington JD, Koshi J, Murphy PJ. Clear cell glycogenesis in multiple syringoma. Arch. Dermatol. 1972;106:353-356.
Alcantara A, Mercadillo P, Hernández M, Sastre N, Ramos R. Siringoma de ceúlas claras. Estudio clínico-patológico de un caso y revisión de la literatura. Rev. Med. Hosp. Gen. Mex. 2001; 64(2):97-99.
Guijarro J, Bañuls J, Carnero L, Albares M, Botella R. Siringoma de células claras y diabetes mellitus. Actas Dermosifiliogr. 2001; 92:291-295.
Furve M, Hori Y, Nkabayashi Y. Clear cell syringoma, association with diabetes mellitus. Am J Dermatopathol 1993;15:166-164.
Rodríguez-Peralto JL, Calzado L, Vanaclocha F. Psoriasis. e-dermatosis 2010:124:516-122.
Puig-Sanz L. La psoriasis, ¿una enfermedad sistémica? Actas Dermosifiliogr. 2007; 98:396-406.
Shapiro J, Cohen A, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A. The association between psoriasis, diabetes mellitus and atherosclerosis in Israel: A case-control study. J Amer. Acad. Dermatol. 2007; 56(4)629-634.
Sentochnik D, Eliopoulos G. Infección y diabetes. En: Kahn R, et al. Joslin´s Diabetes Mellitus. 14º Ed. Barcelona: Lippincot Williams & Wilkins, 2007;60:1017-1020.
Sasaki A, Horiuchi N, Hasegawa K, et al. Mortality and causes of death in type 2 diabetic patients: a long-term follow-up study in Osaka district, Japan. Diabetes Res. Clin. Pract. 1989;7:33-40.
Brayton RG, Stokes PE, Schwartz MS, et al. Effect of alcohol and various diseases on leukocyte mobilization phagocytosis and intracellular bacterial killing. N Engl. J Med. 1970; 282:123-128.
Mowat AG, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl. J Med. 1971; 284:621-627.
Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes mellitus. Diabetes 1974; 23:9-15.
Tan JS, Anderson JL, Watanakunakorn C, et al. Neutrophil dysfunction in diabetes mellitus. J Clin Lab Med 1975; 85:26-33.
Dziatkowiak H, Kowalska M, Denys A. Phagocytic and bactericidal activity of granulocytes in diabetic children. Diabetes 1982;31:1041-1043.
Katz S, Klein B, Elian I, et al. Phagocytic activity of monocytes from diabetic patients. Diabetes Care 1983; 6:479-482.
Mac Cuish AC, Urbaniak SJ, Campbel CJ, et al. Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin- dependent diabetes patient. Diabetes 1974; 25:908-912.
Bonifaz A. Micología Médica Básica. México: Menéndez Editores, 2000; 3:35-95.
Tarango V. Dermatofitos: epidemiología y cuadros clínicos. En: Menéndez T, Hernández H. Actualidades en micología médica. 5º Ed. México: Dr. Teófilo Herrera, 2011:14:115-117.
Alteras I, Saryt E. Prevalence of pathogenic fungi in the toe-webs and toe- nails of diabetic patients. Mycopathologia 1979;67:157-159.
Greene RA. Scher RK. Nail changes associates with diabetes mellitus. Dermatology 1987; 16:1015-1021.
Buxton P, et al. Prevalence and epidemiology of toenail onychomicosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998; 139:665-671.
Cornsistein W, Mora A, Orellana N, Capparelii FJ, del Castillo M. Candida: epidemiología y factores de riesgo. Rev. Enferm. Infecc. Microbiol. Clin. 2013; 31(6):380-384.
Turunc T, Demiroglu YZ, Aliskah h, Colakoglu S, Arslan H. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res. Clin. Pract. 2008; 82(2):203-208.
Zaballos P, Ara M, Pozo A, et al. Mucormicosis rinocerebral fulminante. Actas Dermosifiliogr. 2003; 94(9)624-626.
Utz JP, Shadomy HJ, Deep fungal infections. In: Fitzpatrick TB, Eisen AZ, Wolff D, et al, eds. Dermatology in general medicine. New York: Mc Graw-Hill 2000; 2248-2275. .
Gabillot-Care M, Roujeau JC. Acute bacterial skin infections and cellulitis. Curr. Opin. Infect. Dis. 2007; 20:118-123.
Rogers RL, Perkins J. Skin and soft tissue infections. Prim Care 2006;33:697- 710.
Peñaloza-Martínez JA, López Navarro A. Corinebacteriosis cutánea. Rev. Centro Derm. Pascua 2001; 3:141-146.
Arce M, Arenas R. Eritrasma, una revisión. Dermatología 1997; 41(4):151-154.
Cabo H, Franco de Montes de Oca N, Tzovanis MC, Gallardo H. Eritrasma generalizado. Med. Cutan Ibero Lat. Am. 1983; 11:129-132.
Arce M, Moncada M, Arenas R. Búsqueda intencionada de eritrasma y su frecuencia relativa en la consulta del servicio de dermatología. Dermatología 1997; 41:(6):205-208.
Montes LF, Dobson H, Dodge BG, Knowles WR. Erythrasma and diabetes mellitus. Arch. Dermatol. 1969; 99:969-980.
Parra P, Pérez S, Patiño ME, Castañeda S, García J. Actualización en fascitis necrotizante. Semin. Fund. Esp. Reumatol. 2011; 20:1-8.
Quirk WF, Sternbach G, Joseph J. Infection with flesh eating bacteria. J Emerg. Med. 1996; 14:747-753.
Nowak R. Flesh-eating bacteria: Not new, but still worrisome. Science 1994; 264:1655-1658.
Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis o seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997; 103:18-24.
Navarro JA. Gangrena de Fournier. Rev. Eviden. Invest. Clin. 2010; 3(1)51- 57.
Eke N. Fournier´s gangrene: a review of 1726 cases. Br J Surg 2000; 87:718- 728.
Ersy A, Yilmaz G, Akgun Y, Celik Y. Factors affecting mortality of Fournier´s gangrene: review of 70 patients. Anz. J Surg. 2007; 77:43-48.
Hurley HJ. The eccrine sweat glands. In: Moschella SL, Hurley HJ, eds. Dermatology. Vol. 2, 2º Ed. Philadelphia: WB Saunders, 1985.
Calvagno M. Pie diabético. En: Diabetes Mellitus. 4º Ed. Buenos Aires. Argentina: Librería Akadia Editorial, 1ra. Reimpresión, 2012; 33:612-627.
International consensus on the Diabetic Foot. By the International Working Group on the Diabetic Food. Holland, Mayo 2003
Giurini J. El pie diabético: Estrategias de tratamiento y prevención de las úlceras. En Kahn R. y colaboradores. Joslin´s Diabetes Mellitus. 14º Ed. Barcelona, España: Lippincott Williams & Wilkins 2007; 62:1049-1060.
Ruiz-Morosini ML, Ferrari N. Insulinoterapia. En: Diabetes Mellitus. 4º Ed. Buenos Aires. Argentina: Librería Akadia Editorial, 1ra. Reimpresión, 2012; 16:293-295.
Litt JZ. Drug eruption reference manual. New York: Parthenon Publishing; 2000.
Kono T, Hayami M, Kobayashi H, et al. Acarbose induced generalized erythema multiforme. Lancet 1999; 354:396-397.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
